NAS10029,273+1.09%S&P7,677+0.70%GOLD$4,016−0.55%BTC$79,739−0.33%VIX18.43+0.22%latest tape · as of 08:03 UTC
The Screen · Industrials · Specialty Industrial Machinery
ITT Inc
ITT · the NYSE · USD · 11,600 employees
ITT Inc., together with its subsidiaries, manufactures and sells engineered critical components and customized technology solutions for the transportation, industrial, and energy markets.
Positioning political selling, disclosed 2026-09-29
Options put/call open interest 173.45, read 2026-10-25
Ethical passes the values gate
Price201.04 USD
Fair value228.55
Ethical score70.0/100
Our investment reviews on this name
2026-10-24Read Distribution201.04+0.0% to today Markdown gives way to Distribution first Distribution read since July
2026-10-20Read Markdown201.04+0.0% to today Markup gives way to Markdown after an 8% slide in 7 weeks
2026-09-02Read Markup219.40-8.4% to today Accumulation gives way to Markup after a 10% rise in 4 weeks
2026-08-02Read Accumulation198.99+1.0% to today ✓Distribution gives way to Accumulation after a 5% rise in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
ITT Inc holds its Distribution at $201.04. The statistical read favours the sellers, held for 3 days.
As held on the ledger · 2026-10-15
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 3 days
Price at the screen
$201.04
Valuation
40.25 trailing · 21.41 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.28
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
13.74%
Below 33%
Interest-bearing debt is just 13.7% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
39.31%
Below 49%
Money owed to the company is 39.3% of assets, under the 49% limit.
Pass
Revenue purity
0.27%
Below 5%
Only 0.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
ITT clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 14%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ITT's ethical verdict changes
Today ITT passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-15 screen. The gold marker is the market price at the same screen. A 13.7% margin of safety to the base estimate.
Third-party analyst targets: 13 covering, consensus None. The average target sits +32% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Engineered Parts Quietly Powering Key Industries
Picture the brake caliper on a freight train or the valve inside a refinery pump. ITT makes those critical components across transport, industrial and energy markets. Revenue rose 33% while the firm still clears a basic ethical screen.
The business trades at 20.8 times forward earnings with an 11% profit margin and 12% ROE. Our fair value sits at 215.53 against the current 192.51 price, giving a modest 12% margin of safety. Yet the narrow moat and opportunity rating of none keep us from seeing a compelling edge.
Thirteen analysts point to a 246 median target, but industrial demand can swing sharply. A slowdown in any segment could compress multiples quickly even if the growth rate holds for now. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ITT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-26Distribution$201.04+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution$201.04+0.0%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$201.04+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown$201.04+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$201.04+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown · changed$201.04-0.2%Entry 8
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markup$201.37-2.1%Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245.
2026-10-02Markup$205.68-6.3%Entry 6
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245.
2026-09-02Markup · changed$219.40+10.3%Entry 5
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (13 analysts) rates it buy, with a mean price target of $245.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
